Treatment of neuroblastoma with 131I‐metaiodobenzylguanidine: Experience of the Münster/Kassel group
- 1 January 1987
- journal article
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 15 (4) , 196-198
- https://doi.org/10.1002/mpo.2950150411
Abstract
I‐131‐metaiodobenzylguanidine was used for treatment of neuroblastoma stage IV in three children after surgery and or chemotherapy had failed to be effective. In two of the children with multilocular lesions, after an impressive improvement of clinical symptoms tumor progression was observed. Because in about 25% of children with relapsing neuro‐blastoma complete remission may be achieved by combining surgery, chemotherapy, and I‐ 131‐MIBG treatment, this therapeutic modality should be included in the therapeutic strategy of stage III and IV neuroblastoma.Keywords
This publication has 3 references indexed in Scilit:
- Erste Erfahrungen in der Behandlung von Kindern mit metastasiertem und rezidiviertem Neuroblastom mit Metajodbenzylguanidin*Klinische Padiatrie, 1986
- Therapy of the Neuroblastoma with 131I-MIBGPublished by Springer Nature ,1986
- IMAGING OF MEDULLARY THYROID CANCER WITH 131I-MIBGThe Lancet, 1984